FutureChem Signs Pharmaceutical Supply Contract Worth 1.5 Billion KRW

[Asia Economy Reporter Hwang Yoon-joo] FutureChem announced on the 18th that it has signed a supply and consignment contract for clinical trial drugs worth 1,541,260,000 KRW with Avid Radiopharmaceuticals, Inc.


This amount corresponds to 13.04% of recent sales, and the contract period is from April 16, 2022, to December 31, 2024.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.